| Robert E Fitzgibbons, MD | |
|
1610 Dry Creek Dr, Longmont, CO 80503-6405 | |
| (303) 772-1600 | |
| (970) 493-0521 |
| Full Name | Robert E Fitzgibbons |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 37 Years |
| Location | 1610 Dry Creek Dr, Longmont, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407884620 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | DR0032724 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Longmont United Hospital | Longmont, CO | Hospital |
| Longs Peak Hospital | Longmont, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopaedic And Spine Center Of The Rockies Pc | 0244126365 | 126 |
News Archive
The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.
Many reformers undoubtedly believe that passage of the health overhaul law laid the issue to rest. But policy's wheels continue to turn, and the process is anything but over. … From where we sit, with the withering campaign that must be in the works, the odds of the new law remaining intact, with teeth, are questionable. For reforms to succeed, then, steady vigilant hands, focused on the nation's larger interest, will be critical (Brian Klepper and David Kibbe, 9/20).
PDL BioPharma, Inc. today announced that it has entered into a non-exclusive license agreement with Eli Lilly and Company under PDL's Queen et al patents with respect to teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next generation anti-CD3 molecules.
Designed for laboratories tasked with handling larger sample volumes - Rocket evaporators from Genevac set the standard for productive, sample-safe operation.
› Verified 6 days ago
| Entity Name | Orthopaedic & Spine Center Of The Rockies Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770579385 PECOS PAC ID: 0244126365 Enrollment ID: O20040225000914 |
News Archive
The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.
Many reformers undoubtedly believe that passage of the health overhaul law laid the issue to rest. But policy's wheels continue to turn, and the process is anything but over. … From where we sit, with the withering campaign that must be in the works, the odds of the new law remaining intact, with teeth, are questionable. For reforms to succeed, then, steady vigilant hands, focused on the nation's larger interest, will be critical (Brian Klepper and David Kibbe, 9/20).
PDL BioPharma, Inc. today announced that it has entered into a non-exclusive license agreement with Eli Lilly and Company under PDL's Queen et al patents with respect to teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next generation anti-CD3 molecules.
Designed for laboratories tasked with handling larger sample volumes - Rocket evaporators from Genevac set the standard for productive, sample-safe operation.
› Verified 6 days ago
| Entity Name | Froc Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210933 PECOS PAC ID: 2567403728 Enrollment ID: O20050518000290 |
News Archive
The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.
Many reformers undoubtedly believe that passage of the health overhaul law laid the issue to rest. But policy's wheels continue to turn, and the process is anything but over. … From where we sit, with the withering campaign that must be in the works, the odds of the new law remaining intact, with teeth, are questionable. For reforms to succeed, then, steady vigilant hands, focused on the nation's larger interest, will be critical (Brian Klepper and David Kibbe, 9/20).
PDL BioPharma, Inc. today announced that it has entered into a non-exclusive license agreement with Eli Lilly and Company under PDL's Queen et al patents with respect to teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next generation anti-CD3 molecules.
Designed for laboratories tasked with handling larger sample volumes - Rocket evaporators from Genevac set the standard for productive, sample-safe operation.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert E Fitzgibbons, MD 2500 E Prospect Rd, Fort Collins, CO 80525-9718 Ph: (970) 493-0112 | Robert E Fitzgibbons, MD 1610 Dry Creek Dr, Longmont, CO 80503-6405 Ph: (303) 772-1600 |
News Archive
The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.
Many reformers undoubtedly believe that passage of the health overhaul law laid the issue to rest. But policy's wheels continue to turn, and the process is anything but over. … From where we sit, with the withering campaign that must be in the works, the odds of the new law remaining intact, with teeth, are questionable. For reforms to succeed, then, steady vigilant hands, focused on the nation's larger interest, will be critical (Brian Klepper and David Kibbe, 9/20).
PDL BioPharma, Inc. today announced that it has entered into a non-exclusive license agreement with Eli Lilly and Company under PDL's Queen et al patents with respect to teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next generation anti-CD3 molecules.
Designed for laboratories tasked with handling larger sample volumes - Rocket evaporators from Genevac set the standard for productive, sample-safe operation.
› Verified 6 days ago
Peter Wood, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1610 Dry Creek Dr, Longmont, CO 80503 Phone: 303-772-1600 Fax: 970-493-0521 | |
Dr. James A Britton, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1925 Mountain View Ave, Longmont, CO 80501 Phone: 720-494-3132 Fax: 720-494-3107 | |
Mr. John O Cletcher Jr., M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1610 Dry Creek Drive, Longmont, CO 80503 Phone: 303-772-1600 | |
Dr. Gavin Brett Bishop, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1610 Dry Creek Dr, Longmont, CO 80503 Phone: 303-772-1600 Fax: 303-772-9317 | |
Lucas G Schnell, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1610 Dry Creek Dr, Longmont, CO 80503 Phone: 303-772-1600 Fax: 303-772-9317 | |
Timothy J Pater, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1610 Dry Creek Dr, Longmont, CO 80503 Phone: 303-772-1600 Fax: 970-493-0521 | |
Kenneth J Cavanaugh, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1551 Professional Ln, Suite 200, Longmont, CO 80501 Phone: 303-772-1600 Fax: 303-772-9317 |